Mays Cancer Center at UT Health San Antonio
- World rank, 2022–2025
- #13,525 of 28,054 · #27,295 all time
- Rank in United States
- #1,879 of 4,192
- Research works
- 138 ▲ 4725% vs 2013–17
- Citations
- 2.4k 17.0 per fractional work
- Top-10% rate
- 17.3% record average 16.5%
- Open access
- 58% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.0×. Every wedge is a field page.
- Immunology and Microbiology 4.0×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Medicine 3.2×
- Health Professions 1.3×
- Nursing 0.7×
- Economics, Econometrics and Finance 0.6×
- Neuroscience 0.5×
- Psychology 0.5×
- Physics and Astronomy 0.4×
- Chemistry 0.3×
- Mathematics 0.2×
- Decision Sciences 0.2×
- Materials Science 0.2×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Computer Science 0.0×
- Engineering 0.0×
Which keywords describe research at Mays Cancer Center at UT Health San Antonio?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Cancer, Prognostic Factors, Tumor Microenvironment, Prognostic Scoring System, Radiotherapy and Lymphoma.
- Survival
- Cancer Immunotherapy
- Mutational Signatures
- Cancer Genomics
- Breast Cancer
- Neoadjuvant Therapy
- Genetic Pathogenesis
- Molecular Profiling
- Molecular Characterization
- Genomic Instability
- Cancer Incidence
- Gene Expression
- PET Imaging
- Quality of Life
- Lymphoma
- Cancer Therapy
- Prognostic Scoring System
- Prognostic Factors
- Inflammation
- Immunotherapy
- Chemotherapy
- Cancer
- Epidemiology
- Tumor Microenvironment
- Radiotherapy
- JAK2 Mutation
- Myelofibrosis
- Treatment
- Rituximab
- Targeted Therapy
- Classification
- Aging
- Gene Expression Profiling
- Genetic Mutations
- Hodgkin's Lymphoma
- Mutation
- Prognosis
- Molecular Classification
- Population-Based Study
- Resistance
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy5▲ 11×18 topics
- Immunotherapy5▲ 11×14 topics
- Cancer4▲ 5.0×27 topics
- Inflammation4▲ 2.9×20 topics
- Epidemiology4▲ 1.49×28 topics
- Prognostic Factors3▲ 11×10 topics
- Tumor Microenvironment3▲ 11×7 topics
- Prognostic Scoring System3▲ 114×2 topics
- Radiotherapy3▲ 11×7 topics
- Cancer Therapy3▲ 7.2×12 topics
- JAK2 Mutation3▲ 177×1 topic
- Lymphoma3▲ 26×3 topics
- Myelofibrosis3▲ 177×1 topic
- Quality of Life3▲ 2.8×8 topics
- Treatment3▲ 3.2×14 topics
- PET Imaging2▲ 21×3 topics
- Rituximab2▲ 24×3 topics
- Gene Expression2▲ 5.6×10 topics
- Targeted Therapy2▲ 15×5 topics
- Cancer Incidence2▲ 23×3 topics
- Classification2▲ 6.8×2 topics
- Genomic Instability2▲ 28×2 topics
- Aging2▲ 5.7×6 topics
- Molecular Characterization2▲ 16×4 topics
- Gene Expression Profiling2▲ 34×2 topics
- Molecular Profiling2▲ 28×2 topics
- Genetic Mutations2▲ 6.3×10 topics
- Genetic Pathogenesis2▲ 49×1 topic
- Hodgkin's Lymphoma2▲ 49×1 topic
- Neoadjuvant Therapy2▲ 11×5 topics
- Mutation2▲ 13×3 topics
- Breast Cancer2▲ 9.8×7 topics
- Prognosis2▲ 7.1×5 topics
- Cancer Genomics2▲ 31×1 topic
- Molecular Classification2▲ 15×3 topics
- Mutational Signatures2▲ 31×1 topic
- Population-Based Study2▲ 33×2 topics
- Cancer Immunotherapy1▲ 14×3 topics
- Resistance1▲ 20×2 topics
- Survival1▲ 16×3 topics
Which research topics does Mays Cancer Center at UT Health San Antonio publish most on?
By volume in 2022–2025: Myeloproliferative Neoplasms: Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 3 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 3 Cancer Genomics and Diagnostics Cancer Research 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Global Cancer Incidence and Screening Oncology 1 works
- 6 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 7 Acute Myeloid Leukemia Research Hematology 1 works
- 8 Glioma Diagnosis and Treatment Genetics 1 works
- 9 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 10 Cancer Treatment and Pharmacology Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mays Cancer Center at UT Health San Antonio's research output changed?
Output in 2018–2022 was 4725% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Antonio
- The University of Texas at San Antonio Health Science Center
- The University of Texas at San Antonio
- Southwest Research Institute
- Trinity University
- San Antonio College
- Wilford Hall Ambulatory Surgical Center
- Brooke Army Medical Center
- Joint Base San Antonio
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.